Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SC Disease”

410 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 410 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT02455011
What this trial is testing

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusDiabetes
REMD Biotherapeutics, Inc. 75
Early research (Phase 1)Study completedNCT03735225
What this trial is testing

Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration

Who this might be right for
Hypoglycemia
Zealand Pharma 60
Large-scale testing (Phase 3)Study completedNCT02611817
What this trial is testing

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Takeda 644
Early research (Phase 1)WithdrawnNCT00335855
What this trial is testing

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Not applicableLooking for participantsNCT06767917
What this trial is testing

A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MB

Who this might be right for
Cataract
Bausch & Lomb GmbH 150
Testing effectiveness (Phase 2)Study completedNCT01560286
What this trial is testing

Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Who this might be right for
Phenylketonuria
BioMarin Pharmaceutical 24
Not applicableStudy completedNCT03346265
What this trial is testing

Progressive Modular Rebalancing (RMP) System Rehabilitation Combined With Sensory Cues for Rehabilitation of Patients With PD

Who this might be right for
Parkinson DiseaseMovement Disorders
University of Roma La Sapienza 47
Not applicableStudy completedNCT01521884
What this trial is testing

Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy

Who this might be right for
Rheumatoid Arthritis
Pfizer 62
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Large-scale testing (Phase 3)Study completedNCT00671034
What this trial is testing

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 166
Testing effectiveness (Phase 2)Active Not RecruitingNCT02677922
What this trial is testing

Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 130
Not applicableUnknownNCT05317351
What this trial is testing

A Prospective Randomized Study Comparing the Adenoma Detection Yield of SC, AI and Combined AI and G-EYE®

Who this might be right for
Colorectal (Colon or Rectal) CancerAdenoma
Smart Medical Systems Ltd. 2,160
Not applicableStudy completedNCT04678037
What this trial is testing

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Hemoglobin CSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableStudy completedNCT06434519
What this trial is testing

Metronidazole SC Penetrance With Moisturizers

Who this might be right for
Rosacea, Erythematotelangiectatic
Duke University 21
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Large-scale testing (Phase 3)WithdrawnNCT02052219
What this trial is testing

BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Anthera Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT04735432
What this trial is testing

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 110
Load More Results